KZA 0.00% 8.0¢ kazia therapeutics limited

26th Annual Meeting and Education Day of the Society for...

  1. 1,152 Posts.
    lightbulb Created with Sketch. 832
    26th Annual Meeting and Education Day of the Society for Neuro-Oncology November 18 - 21, 2021

    IMO Kazia management will wait for the final data from paxalisib phase2 Kazia / Danna-Farber GBM trial results, and then submit a New Drug Application (NDA) submission, which may result in a faster product approval for paxalisib.

    Regards.



 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.